Infectious disease expert discusses key data releases from ID Week 2020 within the field of HIV care.
EP. 1: Screening Trends and HIV Status Effects on COVID-19 Outcomes
An infectious disease expert discusses the impact on HIV screening caused by the COVID-19 pandemic as well as the effects of HIV status on COVID-19 outcomes.
EP. 2: New Study Findings on Weight Gain and Integrase Inhibitors
An expert physician reflects upon the notable adverse effect of weight gain seen in HIV care with integrase inhibitors and the implications of recent study results.
EP. 3: GI Tolerability of D/C/F/TAF vs TDF: Data from ID Week 2020
A key opinion leader reviews findings presented at ID Week 2020 from a post-hoc analysis of the AMBER study comparing GI tolerability of D/C/F/TAF to TDF.
EP. 4: Recent Data on Anti-Retroviral Therapy Adherence Barriers
An infectious disease expert discusses data on practical, physical, and psychological barriers to antiretroviral therapy adherence for patients with HIV.
EP. 5: Flu Vaccine Data and HIV Care Highlights from ID Week 2020
Moti Ramgopal, MD, FACP, FIDSA, CPI, reviews data on high-dose versus standard-dose flu vaccines and additional findings in HIV care from ID Week 2020.
2 Commerce Drive Cranbury, NJ 08512